Leonid Cherkassky

Research Fellow

Leonid Cherkassky

Research Fellow

Awards and Scholarships

American College of Surgeons Research Scholarship

Current Employment

Surgical Resident, Rhode Island Hospital/Brown University, Providence, RI.

Publications

Manuscripts

  • Kadota K, Yeh Y-C, Villena-Vargas J, Cherkassky L, Drill EN, Sima CS, Jones DR, Travis WD, Adusumilli PS. Tumor Budding Correlates with Protumor Immune Microenvironment and is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma. CHEST. 2015 Apr 2. [Epub ahead of print] PMID: 25836013.
  • Adusumilli PS, Cherkassky L, Villena-Vargas J, Colovos C, Servais E, Plotkin J, Jones DR, Sadelain M. Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity. Sci Transl Med. 2014 Nov 5;6(261):261ra151. (PMC4373413) PMID: 25378643.

Abstracts/Presentations

  • Cherkassky L, Morello A, Villena-Vargas J, Mayor M, Jones DR, Sadelain M, Adusumilli PS. Genetic-Engineering Strategies to Enhance CAR T-Cell Therapy Efficacy against PD-L1 Expressing Lung Adenocarcinoma and Mesothelioma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Villena-Vargas J, Cherkassky L, Colovos C, Servais E, Rodriguez L, Rusch VW, Sadelain M, Adusumilli PS. Critical role of CD28 costimulation in tumor-targeted T-cell therapy clinical trial for pleural malignancies. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer, October 27-30, 2013, Sydney, Australia. (Oral Presentation)
  • Villena-Vargas J, Rodriguez L, Moroz M, Cherkassky L, Rusch VW, Sadelain M, Ponomarev V, Adusumilli PS. T-cell imaging to noninvasively monitor adoptive T-cell therapy for thoracic malignancies. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer, October 27-30, 2013, Sydney, Australia. (Oral Presentation)
  • Kadota K, Nitadori J, Cherkassky L, Rusch VW,  Travis WD, Sadelain M, Adusumilli PS. Prognostic impact of tumor-infiltrating immune cells in lung squamous cell carcinoma. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer, October 27-30, 2013, Sydney, Australia. (Oral Presentation)
  • Kadota K, Cherkassky L, Rusch VW, Travis WD, Sadelain M, Adusumilli PS. Nuclear estrogen receptor-α expression is a significant prognostic factor for recurrence, independent from the IASLC/ATS/ERS classification, in patients with pathologic stage T1aN0M0 disease, and correlates with poor prognostic immune microenvironment in lung adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer, October 27-30, 2013, Sydney, Australia. (Oral Presentation)